Pharmaceutical

NPX-267 by NextPoint Therapeutics for Renal Cell Carcinoma: Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Renal Cell Carcin...

Jun 14, 2024

NPX-267 is under clinical development by NextPoint Therapeutics and currently in...

NPX-267 by NextPoint Therapeutics for Osteosarcoma: Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Osteosarcoma: Lik...

Jun 14, 2024

NPX-267 is under clinical development by NextPoint Therapeutics and currently in...

NPX-267 by NextPoint Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Non-Small Cell Lu...

Jun 14, 2024

NPX-267 is under clinical development by NextPoint Therapeutics and currently in...

NPX-267 by NextPoint Therapeutics for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Transitional Cell...

Jun 14, 2024

NPX-267 is under clinical development by NextPoint Therapeutics and currently in...

NPX-267 by NextPoint Therapeutics for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Pancreatic Ductal...

Jun 14, 2024

NPX-267 is under clinical development by NextPoint Therapeutics and currently in...

PF-07960613 by Pfizer for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval

PF-07960613 by Pfizer for Respiratory Syncytial Virus (...

Jun 14, 2024

PF-07960613 is under clinical development by Pfizer and currently in Phase II fo...

NPX-267 by NextPoint Therapeutics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Triple-Negative B...

Jun 14, 2024

NPX-267 is under clinical development by NextPoint Therapeutics and currently in...

United Laboratories International gets grant for method for removing contaminant material from oil and gas equipment

United Laboratories International gets grant for method...

Jun 12, 2024

Discover a patented method for removing contaminant material from oil and gas in...

Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases

Syros Pharmaceuticals gets grant for CDK7 inhibitors fo...

Jun 12, 2024

Discover how Syros Pharmaceuticals' patented compounds inhibit CDK7, inducing ce...

BioMarin Pharmaceutical gets grant for treatment of adolescent PKU patients using avpal variant

BioMarin Pharmaceutical gets grant for treatment of ado...

Jun 12, 2024

Reduce blood phenylalanine levels in adolescents with PKU using AvPAL variants. ...

Silence Therapeutics gets grant for compound for rna interference therapy in treating liver disease

Silence Therapeutics gets grant for compound for rna in...

Jun 12, 2024

Discover the groundbreaking patent by Silence Therapeutics Plc for a compound re...

Piramal Enterprises gets grant for pharmaceutical kit for cancer treatment with CDK and antioxidant

Piramal Enterprises gets grant for pharmaceutical kit f...

Jun 12, 2024

Discover the groundbreaking patent by Piramal Enterprises Ltd for a pharmaceutic...

AstraZeneca champions early kidney disease diagnosis with modelling data

AstraZeneca champions early kidney disease diagnosis wi...

Jun 12, 2024

Early diagnosis of chronic kidney disease has both economic and environmental be...

Tacalyx extends seed funding round to raise over €14m

Tacalyx extends seed funding round to raise over €14m

Jun 12, 2024

Cancer-focused biotech Tacalyx has extended its seed financing round to raise ov...

UK clinical trial sector must address prolonged timelines, say experts

UK clinical trial sector must address prolonged timelin...

Jun 12, 2024

Experts highlighted the need to address a gap in UK regulatory timelines compare...

J&J-backed Bright Peak secures $90m to advance immunoconjugate programme

J&J-backed Bright Peak secures $90m to advance immunoco...

Jun 12, 2024

The funds will be used to advance PD1-IL18 immunoconjugate BPT567 into early-sta...

54
55
56
57
58